SRDX
Surmodics, Inc.

190
Loading...
Loading...
News
all
press releases
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.
Zacks·1mo ago
News Placeholder
More News
News Placeholder
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for SurModics (SRDX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates
SurModics (SRDX) delivered earnings and revenue surprises of +128.57% and +4.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +45.83% and +0.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates
Evolus (EOLS) delivered earnings and revenue surprises of -166.67% and -16.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?
Zacks·3mo ago
News Placeholder
Why Is SurModics (SRDX) Up 6% Since Last Earnings Report?
Zacks·4mo ago
News Placeholder
Surmodics Announces Successful Early Clinical Use of Pounce XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the successful early clinical use of its Pounce...
Business Wire·7mo ago
News Placeholder
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended...
Business Wire·8mo ago
News Placeholder
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and...
Business Wire·10mo ago

Latest SRDX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.